Grand Pharmaceutical Group Limited (0512.HK)
HKD 4.76
(-0.83%)
HKD 4.76
(-0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.22 Billion | 1.91 Billion | 2.12 Billion | 1.77 Billion | 1.18 Billion | 1.4 Billion |
| Net Income | 1.87 Billion | 2.07 Billion | 2.4 Billion | 1.79 Billion | 1.15 Billion | 712.66 Million |
| Depreciation & Amortization | 392.21 Million | 394.91 Million | 339.51 Million | 287.06 Million | 477.13 Million | 236.31 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -123.17 Million | -892.91 Million | -298.63 Million | -227.6 Million | -349.58 Million | -263.69 Million |
| Other non-cash items | 870.67 Million | 335.67 Million | -321.18 Million | -76.13 Million | -90.91 Million | 723.02 Million |
| Investing Cash Flow | -521.69 Million | -2.57 Billion | -2.04 Billion | -2.05 Billion | -489.72 Million | -4.05 Billion |
| Investments in PPE | -497.68 Million | -1.67 Billion | -627.39 Million | -467.24 Million | -599.38 Million | -372.85 Million |
| Acquisitions | -169.81 Million | -267.23 Million | -266.75 Million | -8.57 Million | -104.24 Million | -3.62 Billion |
| Investment purchases | -1.66 Billion | -2.07 Billion | -1.41 Billion | -1.44 Billion | -131.59 Million | 3.61 Billion |
| Sales/Maturities of investments | 1.65 Billion | 1.43 Billion | 219.39 Million | 32.86 Million | 320.42 Million | 2.95 Million |
| Other Investing Activities | 150.98 Million | -580.36 Million | 46.47 Million | -160.46 Million | 25.07 Million | -3.68 Billion |
| Financing Cash Flow | -1.68 Billion | 464.49 Million | -195.08 Million | 899.79 Million | -497.96 Million | 2.96 Billion |
| Debt repayment | -1.05 Billion | -917.34 Million | -365.3 Million | -241.25 Million | -231.83 Million | -2.22 Billion |
| Dividends payments | -496.94 Million | -390.45 Million | -390.45 Million | -324.24 Million | -290.47 Million | - |
| Common Stock Repurchased | -81.01 Million | -43.98 Million | -143.5 Million | -24.42 Million | -58.79 Million | - |
| Common Stock Issuance | -81.01 Million | -10.85 Million | -5.7 Million | 1.01 Billion | 102.61 Million | 3.42 Billion |
| Other Financing Activities | -25.72 Million | 1.82 Billion | 709.88 Million | 476.05 Million | -19.48 Million | 1.76 Billion |
| Accounts receivables | -198.24 Million | -536.76 Million | -667.54 Million | -113.46 Million | -187.04 Million | -216.71 Million |
| Accounts payables | 290.64 Million | -234.57 Million | 605.5 Million | 2.48 Million | -297.15 Million | 574.82 Million |
| Inventory | -99.4 Million | -295.28 Million | -118.73 Million | -100.96 Million | -65.11 Million | -46.98 Million |
| Other working capital | -116.17 Million | 173.7 Million | -117.85 Million | -15.67 Million | 199.72 Million | -574.82 Million |
| Cash at beginning of period | 1.44 Billion | 1.76 Billion | 1.86 Billion | 1.18 Billion | 985.75 Million | 640.84 Million |
| Cash at end of period | 1.37 Billion | 1.44 Billion | 1.76 Billion | 1.86 Billion | 1.18 Billion | 912.24 Million |
| Capital Expenditure | -497.68 Million | -1.67 Billion | -627.39 Million | -467.24 Million | -599.38 Million | -372.85 Million |
| Effect of forex changes on cash | -124.05 Million | -118.41 Million | 12.64 Million | 60.37 Million | -3.14 Million | -43.74 Million |
| Net cash flow / Change in cash | -72.99 Million | -315.13 Million | -107.1 Million | 687.05 Million | 194.79 Million | 271.4 Million |
| Free Cash Flow | 1.73 Billion | 245.78 Million | 1.49 Billion | 1.3 Billion | 588.21 Million | 1.03 Billion |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.55 Billion | 850.64 Million | 1.87 Billion | 1.02 Billion | 2.07 Billion | 1.36 Billion |
| Depreciation & Amortization | 249.15 Million | 200.65 Million | 392.21 Million | 191.55 Million | 394.91 Million | 222.37 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -303.16 Million | -123.17 Million | - | -892.91 Million | -813.29 Million |
| Other non-cash items | -1.66 Billion | 927.62 Million | 870.67 Million | -201.89 Million | 335.67 Million | 45.7 Million |
| Investing Cash Flow | -871.41 Million | 59.79 Million | -521.69 Million | -575.53 Million | -2.57 Billion | -1.59 Billion |
| Investments in PPE | -192.41 Million | -259.95 Million | -497.68 Million | -228.53 Million | -1.67 Billion | -1.29 Billion |
| Acquisitions | -720.29 Million | -29.56 Million | -169.81 Million | -146.86 Million | -267.23 Million | -267.23 Million |
| Investment purchases | - | -1.45 Billion | -1.66 Billion | -207 Million | -2.07 Billion | -1.44 Billion |
| Sales/Maturities of investments | 16.72 Million | - | 1.65 Billion | - | 1.43 Billion | 1.43 Billion |
| Other Investing Activities | 24.76 Million | 349.3 Million | 150.98 Million | 6.86 Million | -580.36 Million | -25.6 Million |
| Financing Cash Flow | 270.13 Million | -1.22 Billion | -1.68 Billion | -547.4 Million | 464.49 Million | 930.41 Million |
| Debt repayment | -1.21 Billion | -1.1 Billion | -1.05 Billion | -55.09 Million | -917.34 Million | -941.94 Million |
| Dividends payments | -922.88 Million | - | -496.94 Million | -496.94 Million | -390.45 Million | -3000.00 |
| Common Stock Repurchased | - | -1.96 Million | -81.01 Million | -79.04 Million | -43.98 Million | -2.73 Million |
| Common Stock Issuance | - | - | -81.01 Million | - | -10.85 Million | -10.85 Million |
| Other Financing Activities | -19.91 Million | -1.22 Billion | -25.72 Million | -26.51 Million | 1.82 Billion | 2.06 Million |
| Accounts receivables | - | -177.52 Million | -198.24 Million | - | -536.76 Million | -514.24 Million |
| Accounts payables | - | - | 290.64 Million | - | -234.57 Million | - |
| Inventory | - | -99.4 Million | -99.4 Million | - | -295.28 Million | -295.28 Million |
| Other working capital | - | -26.23 Million | -116.17 Million | - | 173.7 Million | -3.77 Million |
| Cash at beginning of period | 1.37 Billion | 693.61 Million | 1.44 Billion | 1.44 Billion | 1.76 Billion | 1.03 Billion |
| Cash at end of period | 763.78 Million | 1.37 Billion | 1.37 Billion | 696.71 Million | 1.44 Billion | 1.44 Billion |
| Capital Expenditure | -192.41 Million | -259.95 Million | -497.68 Million | -228.53 Million | -1.67 Billion | -1.29 Billion |
| Effect of forex changes on cash | - | 139.31 Million | -124.05 Million | -263.37 Million | -118.41 Million | -124.33 Million |
| Net cash flow / Change in cash | -608.59 Million | 678.76 Million | -72.99 Million | -748.65 Million | -315.13 Million | 406.96 Million |
| Free Cash Flow | -51.56 Million | 1.41 Billion | 1.73 Billion | 407.37 Million | 245.78 Million | -105.78 Million |
SMIN
2331
LXRX
NORSF
3711
3728